"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 2 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 6 | 1 | 7 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 3 | 6 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 2 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 3 | 0 | 3 |
| 2020 | 7 | 0 | 7 |
| 2021 | 2 | 1 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Implementing interventions to start HPV vaccination at age 9: Using the evidence we have. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2180250.
-
Optimizing timing of adolescent vaccines: Impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccine series. Hum Vaccin Immunother. 2023 Dec 31; 19(1):2175541.
-
Predicting HPV vaccination among Tdap vaccinated adolescents in Georgia at the county level?. Ann Epidemiol. 2022 06; 70:74-78.
-
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties. Vaccine. 2022 02 23; 40(9):1352-1360.
-
Intervention to Reduce Stigma and Improve Knowledge of HPV and Cervical Cancer in Nigeria: A Community-Based Assessment. Fam Community Health. 2021 Oct-Dec 01; 44(4):245-256.
-
Human Papillomavirus Vaccination Knowledge, Barriers, and Recommendations Among Healthcare Provider Groups in the Western United States. J Cancer Educ. 2022 Dec; 37(6):1816-1823.
-
A narrative review of HPV vaccination interventions in rural U.S. communities. Prev Med. 2021 04; 145:106407.
-
Spatial Access to Vaccines for Children Providers in South Carolina: Implications for HPV Vaccination. Prev Chronic Dis. 2020 12 24; 17:E163.
-
Expanding Indications for the Human Papillomavirus Vaccine: One Small Step for the Prevention of Head and Neck Cancer, but One Giant Leap Remains. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1099-1101.
-
A survey of office practice: Parents, front office staff, nurses and clinicians hold disparate views on adolescent vaccines. Vaccine. 2020 12 14; 38(52):8326-8333.